Public Webinar:

The Utility of Long Acting Medications During

COVID-19 and Beyond

Please join us and Janssen Pharmaceutical Companies of Johnson & Johnson for a public webinar about the efficacy of long acting medications (LAMs). This webinar will highlight the utility of LAMs with leading experts in the field including representatives from: Substance Abuse and Mental Health Services Administration (SAMHSA), National Council for Behavioral Health (NCBH), National Alliance on Mental Illness (NAMI), and CAC Corporate Partners’ physician and researcher representatives. Attendees will learn how LAMs can serve as an optimal treatment modality for a variety of disorders during and beyond the COVID-19 pandemic. Click here for event flyer and here for the agenda.  

August 10, 2020 

10:00 am to 12:00 pm PT

We are excited to announce the following panelists. For more information on the panelists, click on their names for their bios. 

anita-everett_edited.jpg

Anita Everett, MD, DFAPA

Director of Center for Mental

Health Services

Substance Abuse and Mental Health Services Administration

SAMHSA.png
Parks%2C%20Joe%202019_edited.jpg

Joe Parks, MD

Vice President, Practice Improvement & Medical Director

National Council for Behavioral Health

Wayne Drevets.jpg

Wayne C. Drevets, MD

Scientific Vice President

Janssen Pharmaceuticals Research & Development, LLC

J&J.jpg
Andrew Sperling.jpg

Andrew Sperling 
Director of Legislative Advocacy

National Alliance on Mental Illness 

NAMI (national).png
Maye%20Hayes%20Jepson_edited.jpg

Maye Hayes Jepson

Family Mental Health Advocate 

Hiten.jpg

Hiten Patadia, PharmD 

Managed Markets Liaison – West

 Otsuka Pharmaceutical Companies

Otsuka.png

Thank you to the following Corporate Partner for making this event possible!

J&J.jpg